Table 2.
Results of the logistic multivariate regression analysis to determine occurrence of acute symptomatic seizures in ischemic stroke patients.
| Regression Coefficient (Standard Error) | 95% CI - lower bound | Adjusted odds ratio (exp b) | 95% CI - upper bound | |
|---|---|---|---|---|
| Constant | −4.493 | 0.011 | ||
| Age (years) | −0.010* (0.004) | 0.983 | 0.990 | 0.997 |
| Sex (female) | 0.041 (0.089) | 0.875 | 1.042 | 1.242 |
| Diabetes mellitus | −0.153 (0.095) | 0.712 | 0.858 | 1.034 |
| Previous stroke | 0.446** (0.100) | 1.285 | 1.563 | 1.901 |
| Pre-treatment anticoagulants | 0.13 (0.136) | 0.902 | 1.176 | 1.535 |
| Pre-treatment antiplatelets | −0.151 (0.098) | 0.709 | 0.860 | 1.042 |
| Pre-morbid mRS 3-5 | 0.516** (0.100) | 1.377 | 1.676 | 2.040 |
| NIHSS >5 | 0.870** (0.100) | 1.962 | 2.386 | 2.901 |
| Acute infection | 1.220** (0.094) | 2.814 | 3.386 | 4.075 |
| Nagelkerke’s R2 = 0.081 | ||||
* indicates statistical significance at P < 0.05, ** indicates significance at P < 0.001, 95% CI = 95% confidence interval for the adjusted odds ratio (exp b). mRS = modified Rankin Scale, NIHSS = National Institutes of Health Stroke Scale.